ATE126236T1 - Protein-derivate und verfahren zu ihrer herstellung. - Google Patents

Protein-derivate und verfahren zu ihrer herstellung.

Info

Publication number
ATE126236T1
ATE126236T1 AT89308681T AT89308681T ATE126236T1 AT E126236 T1 ATE126236 T1 AT E126236T1 AT 89308681 T AT89308681 T AT 89308681T AT 89308681 T AT89308681 T AT 89308681T AT E126236 T1 ATE126236 T1 AT E126236T1
Authority
AT
Austria
Prior art keywords
protein
group
peptide
co2h
compounds
Prior art date
Application number
AT89308681T
Other languages
English (en)
Inventor
Robin Ewart Offord
Keith Rose
Original Assignee
Robin Ewart Offord
Keith Rose
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robin Ewart Offord, Keith Rose filed Critical Robin Ewart Offord
Application granted granted Critical
Publication of ATE126236T1 publication Critical patent/ATE126236T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57575—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT89308681T 1988-08-26 1989-08-25 Protein-derivate und verfahren zu ihrer herstellung. ATE126236T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888820378A GB8820378D0 (en) 1988-08-26 1988-08-26 Chemical compounds

Publications (1)

Publication Number Publication Date
ATE126236T1 true ATE126236T1 (de) 1995-08-15

Family

ID=10642823

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89308681T ATE126236T1 (de) 1988-08-26 1989-08-25 Protein-derivate und verfahren zu ihrer herstellung.

Country Status (9)

Country Link
EP (1) EP0359428B1 (de)
JP (1) JP2778775B2 (de)
AT (1) ATE126236T1 (de)
AU (1) AU637326B2 (de)
DE (1) DE68923746T2 (de)
ES (1) ES2077582T3 (de)
GB (1) GB8820378D0 (de)
GR (1) GR3017089T3 (de)
WO (1) WO1990002136A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610551D0 (en) 1986-04-30 1986-06-04 Hoffmann La Roche Polypeptide & protein derivatives
US6673347B1 (en) 1986-04-30 2004-01-06 Gryphon Therapeutics Polypeptide and protein derivatives and process for their preparation
GB9004538D0 (en) * 1990-02-28 1990-04-25 Offord Robin E Chemical compounds
WO1992001476A1 (en) * 1990-07-26 1992-02-06 University Of Iowa Research Foundation Novel drug delivery systems for proteins and peptides using albumin as a carrier molecule
US5272253A (en) * 1991-07-01 1993-12-21 Eli Lilly And Company Cluster conjugates of drugs with antibodies
GB9525955D0 (en) * 1995-12-19 1996-02-21 Therexsys Ltd Improved pharmaceutical compositions
US5830852A (en) * 1995-12-19 1998-11-03 Cobra Therapeutics, Ltd. Compositions for insulin-receptor mediated nucleic acid delivery
US7118737B2 (en) 2000-09-08 2006-10-10 Amylin Pharmaceuticals, Inc. Polymer-modified synthetic proteins
DE602006019824D1 (de) 2005-01-26 2011-03-10 Univ Ramot Biologisch aktive silberbeschichtete proteine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71947A (en) * 1984-05-29 1987-10-30 Yeda Research And Dev Comp Ltd Enzyme hydrazides and method for detection and determination of glycoconjugates
PH26813A (en) * 1987-09-02 1992-11-05 Ciba Geigy Ag Conjugates of cytokines with immunoglobulins

Also Published As

Publication number Publication date
JPH03501623A (ja) 1991-04-11
ES2077582T3 (es) 1995-12-01
DE68923746D1 (de) 1995-09-14
GB8820378D0 (en) 1988-09-28
GR3017089T3 (en) 1995-11-30
JP2778775B2 (ja) 1998-07-23
AU4190689A (en) 1990-03-23
AU637326B2 (en) 1993-05-27
EP0359428B1 (de) 1995-08-09
DE68923746T2 (de) 1996-03-21
EP0359428A1 (de) 1990-03-21
WO1990002136A1 (en) 1990-03-08

Similar Documents

Publication Publication Date Title
AU587827B2 (en) Oligopeptide derivatives, their production and their use as surfactantes kind to the skin
AU7433891A (en) Electrochemiluminescent assays
ES8800170A1 (es) Un procedimiento para la preparacion de pirazolo- y piridazo-pirazolinas, -piridazinas y -diacepinas
ES2104558T3 (es) Glicoesfingolipidos con un grupo acoplable en la porcion esfingoide, su preparacion y utilizacion.
DE68923746D1 (de) Protein-Derivate und Verfahren zu ihrer Herstellung.
AU3756497A (en) D-enzyme compositions and methods of their use
ES508587A0 (es) "procedimiento para la preparacion de nuevas amidas de acidos carboxilicos".
ATE51617T1 (de) Verfahren zur herstellung von 4-phenyl-pyrrolderivaten.
AU2851389A (en) Synthetic peptides and mixtures thereof for detecting hiv antibodies
DK0418590T3 (da) Antistoffer, fremstilling deraf og anvendelse deraf
CA2298438A1 (en) Synthetic antigen for the detection of antibodies immunoreactive with hiv virus
ATE86974T1 (de) (2-cyan-2-oximinoacetyl)-aminosaeure-derivate.
PT87628A (pt) Process for the preparation of a fungicidal composition cintaining (2-cyano-2-oxyminoacetyl)-aminoacids derivatives
ATE66534T1 (de) Nortriptylinderivate, verfahren zu ihrer herstellung, deren konjugate mit antigenischen proteinen und enzymen, antikoerper davon und verwandte verfahren zur bestimmung.
Wolcott et al. On the nature of p-nitrothiophenylated myosin
ATE279434T1 (de) Neue (3,4,7,8,9,10) hexahydro-6, 10-dioxo-6h- pyridazino /1, 2-a/ /1, 2/ diazepin-1-carbonsäure-derivate, verfahren zu deren herstellung und deren verwendung zur herstellung pharmazeutischer wirkstoffe
DE59109098D1 (de) Pteridin-Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung zur Herstellung von Immunogenen
TH13553A (th) กรรมวิธีที่ดีขึ้นสำหรับเตรียมเซฟาโลสพอรินส์
ATA73587A (de) Verfahren zur herstellung von alkylaminofuranon- derivativen und deren therapeutisch annehmbaren salzen
JPS6419099A (en) Bonding compound of lipid a monosaccharide analog with sulfur-containing muramic acid dipeptide derivative
ATE137741T1 (de) Aminosäurederivate zur peptidsynthese

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee